Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin Cream 1% vs Soolantra and PrRosiver in Moderate to Severe Facial Rosacea
NCT07795567Phase 1Completed
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ivermectin in rosacea (4 arms). Primary endpoint: Therapeutic equivalence and safety at 12 weeks. Started Dec 2025; status: completed.
02
Drugs
ivermectin
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT07795567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07795567.